non-small-cell lung cancer
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Activity and safety of crizotinib in patients with <span class="gene" id="22954507-0-51-54">ALK</span>-positive <span class="disease" id="22954507-0-64-90">non-small-cell lung cancer</span>: updated results from a phase 1 study.